Tilray Brands (TLRY) Price Forecast: Cannabis Rescheduling Fuels Recovery
Trend Identification & Analysis: How to Read the Market’s Footprints Before the Crowd Does Cannabis-related stocks and ETFs have been among the worst-performing groups in recent years. A peak was …
MSOS: Trump’s Green Light – Why Cannabis Stocks Are Surging On Rescheduling News (Rating Upgrade)
MSOS is upgraded to Buy ahead of US cannabis rescheduling catalysts—Schedule III could end 280E taxes, boost MSO profits, and drive re-ratings. Read more here.
Why are cannabis stocks surging today?
Shares of major cannabis companies rallied sharply on Wednesday after reports suggested the Trump Administration could soon move to reclassify marijuana, a long-awaited step that investors believe …
Canadian Cannabis Stocks Jump on Report U.S. May Move to Reclassify Marijuana
Canadian cannabis companies surged Wednesday after an Axios report said that the Trump Administration could move to reclassify marijuana.
US set to move to reclassify marijuana as early as Wednesday, Axios reports
WASHINGTON, April 22 (Reuters) – The United States administration is expected to move to reclassify marijuana as soon as Wednesday, Axios reported, citing an official familiar with the matter, sending U.S. stocks of cannabis-related companies higher.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Tilray and other pot stocks soar as Trump is reportedly ready to reclassify cannabis
The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive order to reclassify the substance in December.
Tilray Brands (TLRY) Price Forecast: Cannabis Rescheduling Fuels Recovery
Trend Identification & Analysis: How to Read the Market’s Footprints Before the Crowd Does Cannabis-related stocks and ETFs have been among the worst-performing groups in recent years. A peak was …
MSOS: Trump’s Green Light – Why Cannabis Stocks Are Surging On Rescheduling News (Rating Upgrade)
MSOS is upgraded to Buy ahead of US cannabis rescheduling catalysts—Schedule III could end 280E taxes, boost MSO profits, and drive re-ratings. Read more here.
Why are cannabis stocks surging today?
Shares of major cannabis companies rallied sharply on Wednesday after reports suggested the Trump Administration could soon move to reclassify marijuana, a long-awaited step that investors believe …
Here’s why the Tilray Brands stock may surge soon despite major risks
Setup: falling wedge + small inverted H&S with price below key support ($7) and far under 50/100-day EMAs; earnings show record revenue ($206.7M), double-digit growth, improving margins (wellness …
TSX Penny Stocks: 3 Picks With Market Caps Over CA$6M
Despite recent inflationary pressures and concerns about consumer confidence, the Canadian S&P/TSX index has shown resilience, climbing 7.5% from its mid-March low. In such a fluctuating market, penny …
Tilray Posted Record Numbers Last Quarter, but Where the Bulk of Its Growth Has Come From Over the Past 4 Years Might Surprise You
Tilray Brands (NASDAQ: TLRY) is a leading cannabis company based in Canada. However, despite leading the industry, intense competition in the domestic market has made it exceeding …
245% Upside Potential for Sundial Growers (SNDL) After 18% YTD Slide
SNDL Inc. (NASDAQ:SNDL) currently trades at $1.36, while the average analyst price target sits at $4.70, implying an upside of roughly 245% from current levels. SNDL is Canada’s largest private-sector …
NLCP And MSOS: Cannabis REIT Vs. ETF
NLCP’s 12% dividend yield, low debt, and resilient rent collections add downside defense amid cannabis oversupply risks. See more here.
Recent Comments